The 2025 NHMRC Investigator Grant recipients have been announced and Dr Ayesha Shah was successful in the Emerging Leadership 1 (EL1) category for ‘From Bedside to Bench: Improving Clinical Care Using Insights from the Small Intestinal Microbiome’.
Her research explores small intestinal bacterial overgrowth (SIBO), a condition where there are too many bacteria in the small intestine which can negatively impact many diseases. It is common in people with functional gut disorders (e.g. irritable bowel syndrome) causing similar symptoms. Current tests are unreliable, so treatment is often based on trial and error.
Dr Shah aims “to develop better techniques for diagnosing SIBO and create new therapies to modify the gut bacteria to treat or even eradicate SIBO.”
The Investigator Grant scheme is NHMRC’s largest funding scheme and plays a critical role in supporting the Australian health and medical research sector.
NHMRC CEO, Professor Steve Wesselingh, states “Investigator Grants are highly sought after as it provides recipients with certainty, security and flexibility to pursue an ambitious research program across a 5-year period…Congratulations to all researchers receiving funding today.”
Full details of all the researchers and projects funded are available to download on NHMRC’s outcomes of funding rounds page.
We would like to send our congratulations to Dr Ayesha Shah, and all other recipients of the 2025 NHMRC Investigator Grants.
